Skip to main content
Clinical Trials/NCT02363205
NCT02363205
Completed
Not Applicable

Guided Internet-Delivered and Tailored Cognitive Behaviour Therapy for Adolescents With Depression: a Randomized Controlled Trial

Linkoeping University1 site in 1 country70 target enrollmentFebruary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
Linkoeping University
Enrollment
70
Locations
1
Primary Endpoint
Beck Depression Inventory
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to determine whether tailored internet-administrated cognitive behaviour therapy (CBT) is a feasible approach in the treatment of depressive symptoms and comorbid anxiety symptoms.

Detailed Description

As above

Registry
clinicaltrials.gov
Start Date
February 2015
End Date
December 2017
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Linkoeping University
Responsible Party
Principal Investigator
Principal Investigator

Gerhard Andersson

Professor

Linkoeping University

Eligibility Criteria

Inclusion Criteria

  • Be between the ages of 15-19 years old
  • Have symptoms of depression, major depression

Exclusion Criteria

  • Suicidal ideation
  • Alcohol addiction
  • other major primary psychiatric disorder
  • Ongoing psychological treatment
  • recent (during last 4 weeks) change in psychiatric medication

Outcomes

Primary Outcomes

Beck Depression Inventory

Time Frame: Baseline, post treatment, 6 months- and 12 months post treatment

Change from baseline to post treatment, six months and 12 months post treatment.

Secondary Outcomes

  • Beck Anxiety Inventory (BAI)(Baseline, post treatment, 6 months- and 12 months post treatment)
  • Knowledge of CBT strategies (developed by the research group)(Baseline, post treatment, 6 months- and 12 months post treatment)
  • Patient Health Questionnaire (PHQ)(Baseline, post treatment, 6 months- and 12 months post treatment)
  • Social Interaction Anxiety Scale (SIAS)(Baseline, post treatment, 6 months- and 12 months post treatment)
  • The Mood and Feelings Questionnaire (MFQ)(Baseline, post treatment, 6 months- and 12 months post treatment)
  • The General Self-Efficacy Scale (GSE)(Baseline, post treatment, 6 months- and 12 months post treatment)
  • Subscale Life activites, WHO Disability Assessment Schedule 2.0 (WHODAS 2.0)(Baseline, post treatment, 6 months- and 12 months post treatment)

Study Sites (1)

Loading locations...

Similar Trials